JMP Securities downgrades Idenix Pharmaceuticals (Nasdaq: IDIX) from Market Outperform to Market Perform.

Today's downgrade follows Idenix's Q2 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE